All In Biotech

Drug Trial Radar · NCT07053345

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

An Interventional, Open-label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of Esketamine Nasal Spray in Korean Participants With Treatment-Resistant Depression(TRD)

Last checked: Nov 20, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

47

Actual

Start

Jun 9, 2025

Primary completion

Jul 13, 2026

Study completion Jul 13, 2026

Sponsor

Lead sponsor
Janssen Korea, Ltd., KoreaJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jul 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well esketamine nasal spray works in improving depressive symptoms in participants with treatment resistant depression (TRD). This will be assessed by the change from baseline in the Hamilton depression rating scale (HAM-D; 17-item) total score from Day 1 (baseline) to the end of the 4-week treatment phase (Day 28).

Conditions

  • Depressive Disorder, Treatment-Resistant

Interventions

  • Esketamine 56 mgDrug

    Participants will self-administer 56 mg of esketamine as intranasal spray into each nostril.

  • Esketamine 84 mgDrug

    Participants will self-administer 84 mg of esketamine as intranasal spray into each nostril.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Day 28 in Hamilton Depression Rating Scale (HAM-D) Total ScoreTime frame: Baseline up to Day 28

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Cha Ilsan Medical Center

    Goyang Si Gyeonggi Do, South Korea

  • Wonkwang University Hospital

    Iksan, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Kyung Hee University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.